| |
| |
|
| Insider
Information: |
Vaishnaw Akshay |
| Relationship: |
President |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,774 |
|
|
Indirect Shares
|
515 |
|
|
| Direct
Value |
$3,380,345 |
|
|
|
Indirect Value
|
$76,441 |
|
|
| Total
Shares |
23,289 |
|
|
| Total
Value |
$3,456,786 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -26.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2023-08-04 |
22,774 |
2023-08-04 |
515 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-01-24 |
4 |
AS |
$84.57 |
$676,589 |
D/D |
(7,890) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
• – – |
2015-03-17 |
4 |
AS |
$115.29 |
$1,022,568 |
D/D |
(8,750) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
• – – |
2015-03-17 |
4 |
OE |
$7.10 |
$75,875 |
D/D |
8,750 |
8,750 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
• – – |
2015-06-16 |
4 |
OE |
$7.10 |
$75,875 |
D/D |
8,750 |
8,750 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
• – – |
2015-06-16 |
4 |
AS |
$128.10 |
$1,127,239 |
D/D |
(8,750) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,941 |
26,831 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
• – – |
2016-12-30 |
4 |
OE |
$16.43 |
$187,251 |
D/D |
9,547 |
15,297 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-12-12 |
4 |
AS |
$19.00 |
$190,000 |
D/D |
(10,000) |
12,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-12-12 |
4 |
OE |
$9.14 |
$92,400 |
D/D |
10,000 |
22,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-06-17 |
4 |
OE |
$7.10 |
$93,013 |
D/D |
10,625 |
10,625 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-06-17 |
4 |
AS |
$69.33 |
$741,798 |
D/D |
(10,625) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-09-16 |
4 |
OE |
$7.10 |
$93,013 |
D/D |
10,625 |
10,625 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-09-16 |
4 |
AS |
$71.34 |
$765,463 |
D/D |
(10,625) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-12-16 |
4 |
AS |
$91.47 |
$994,588 |
D/D |
(10,626) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-12-16 |
4 |
OE |
$7.10 |
$93,022 |
D/D |
10,626 |
10,626 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-08-09 |
4 |
OE |
$63.00 |
$682,542 |
D/D |
10,834 |
22,049 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-08-09 |
4 |
AS |
$200.00 |
$2,166,800 |
D/D |
(10,834) |
11,215 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
• – – |
2017-05-23 |
4 |
OE |
$21.35 |
$234,850 |
D/D |
11,000 |
21,297 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
• – – |
2017-05-23 |
4 |
AS |
$75.00 |
$825,000 |
D/D |
(11,000) |
10,297 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-06-18 |
4 |
OE |
$42.22 |
$723,495 |
D/D |
11,804 |
25,923 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2022-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,183 |
24,398 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-06-18 |
4 |
AS |
$175.00 |
$2,573,900 |
D/D |
(14,708) |
11,215 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2013-06-11 |
4 |
AS |
$31.07 |
$466,137 |
D/D |
(15,000) |
12,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2013-06-11 |
4 |
OE |
$7.10 |
$127,900 |
D/D |
15,000 |
17,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2013-12-16 |
4 |
OE |
$7.10 |
$127,900 |
D/D |
15,000 |
27,588 |
0 |
- |
|
96 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
